PMEL and melanoma: In summary, we developed a protocol based on ZA-expansion and mRNA electroporation to transfect γ/δ T cells with a gp100/HLA-A2-specific TCR and an MCSP-specific CAR to enlarge the therapeutic options for the adoptive T-cell therapy of melanoma.